Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 6/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6419144 | 0.82 | USP2 (0.41) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL4983188 | 0.80 | USP2 (0.40) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL27117131 | 0.79 | — | — | |
| SCHEMBL8208318 | 0.79 | — | — | |
| SCHEMBL182417 | 0.76 | LMNA (0.35) | LMNAALDH1A1 | |
| SCHEMBL11782848 | 0.76 | USP2 (0.36) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL26126560 | 0.76 | ANPEP (0.41) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL26126558 | 0.76 | ANPEP (0.41) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| Oxirane SCHEMBL2544975 | 0.75 | LMNA (0.31) | LMNA | |
| SCHEMBL2149050 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071031-A1 | COMPOSTABLE CORE-SHELL PARTICLES FOR IMPACT MODIFICATION OF RIGID PLASTICS | UNIV IOWA STATE RES FOUND INC (US) | 2026-03-12 | — | — | US | claimed |
| US-20260071031-A1 | COMPOSTABLE CORE-SHELL PARTICLES FOR IMPACT MODIFICATION OF RIGID PLASTICS | UNIV IOWA STATE RES FOUND INC (US) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071031-A1 | COMPOSTABLE CORE-SHELL PARTICLES FOR IMPACT MODIFICATION OF RIGID PLASTICS | SBDS, COPE, DLST | USP2 148/4885SMN1; SMN2 1713/4885HPGD 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.